Last reviewed · How we verify
NCT06925022: ADVICE Phase 1
Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study (Phase 1)
NA trial testing Strength training session during Early Follicular Phase in Multiple Sclerosis (MS) - Relapsing-remitting in 20 participants. Participants enrolled and being followed up; not accepting new ones.
30 May 2026
Quick facts
| Lead sponsor | Universidad de Almeria |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 20 |
| Start date | 15 December 2024 |
| Primary completion | 30 May 2026 |
| Estimated completion | 30 May 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Strength training session during Early Follicular Phase
- Strength Training Protocol during Late Follicular Phase
- Strength Training during Mid-Luteal Phase
Conditions studied
- Multiple Sclerosis (MS) - Relapsing-remitting — all drugs for Multiple Sclerosis (MS) - Relapsing-remitting →
Sponsor
Universidad de Almeria
Who can join
Adults 18 to 50, female only, with Multiple Sclerosis (MS) - Relapsing-remitting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This phase of the project aims to analyze the interaction between physical exercise and the phases of the menstrual cycle, evaluating its impact on fatigue, functional capacity, and exercise perception in women with and without Multiple Sclerosis. To achieve this, a controlled, single-blind, prospective, 2x3 crossover, randomized clinical trial will be conducted, involving women with Multiple Sclerosis (MS), matched by age, lifestyle habits (smoking, physical activity), and geographic location with a group of women without MS. This study, aligned with previous findings, seeks to deepen the understanding of the role of exercise in managing Multiple Sclerosis symptoms and to promote greater adherence to personalized physical activity programs adapted to the phases of the menstrual cycle.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06925022
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Multiple Sclerosis (MS) - Relapsing-remitting
Currently open trials in the same condition.
- NCT07376772 — Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study · NA · recruiting
- NCT07225361 — Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis · Phase 4 · recruiting
- NCT07355387 — Home Based Functional Balance Intervention for Multiple Sclerosis · NA · recruiting
- NCT06629428 — Effects of Ublituximab on Motor Functions in Multiple Sclerosis · EARLY_PHASE1 · recruiting
- NCT07222618 — "Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS · recruiting
Other Universidad de Almeria trials
Trials by the same sponsor.
- NCT06797817 — Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain · Phase 3 · not yet recruiting
- NCT06522893 — Electrical Dry Needling and Therapeutic Exercise Versus Therapeutic Exercise in Patients With Nonspecific Chronic Neck P · NA · completed
- NCT07093242 — Epigenetic Optimization Through Biofrequency Nutrition · NA · not yet recruiting
- NCT07182747 — Feasibility of a Multidisciplinary Student-Led Program to Improve Frailty in Nursing Home Residents · NA · not yet recruiting
- NCT07015281 — Dry Needling With Percutaneous Electrical Nerve Stimulation and Exercises for Non-specific Chronic Neck Pain · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06925022 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de Almeria
- Last refreshed: 24 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06925022.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing